ASC Valuation

Ambulatory surgery center (ASC) valuations operate differently than physician practice valuations. The asset-intensive nature, complex ownership structures, and regulatory environment create unique dynamics that every ASC seller should understand before engaging buyers.

How ASC Valuation Differs from Practice Valuation

Unlike physician practices where the core asset is provider productivity, ASCs are valued based on:

• Facility-level EBITDA: Cash flow after operating expenses, rent, and management fees but before physician distributions
• Case volume and mix: Higher-acuity cases (orthopedics, spine, cardiac) command premium multiples
• Payer contracts: Fee schedules and out-of-network capabilities
• Physical plant: ORs, capacity, certificate of need status, lease terms
• Ownership structure: JV vs. 100% physician-owned affects valuation approach

Current ASC Valuation Multiples by Specialty

Not all ASC cases are valued equally. Here's how specialty mix affects your multiple:

The big picture: High-acuity orthopedic and cardiac cases that migrated from hospitals to ASCs command the highest multiples because they generate the most revenue per case while demonstrating the ASC shift thesis that PE buyers believe in.

Understanding ASC Ownership Structures

How you own your ASC affects how it's valued and sold:

Joint Venture (JV) with Health System or ASC Platform

Many ASCs operate as JVs where physicians own 49-60% and a health system or ASC management company owns the rest. In a sale:

• You're likely selling your physician ownership stake, not the whole facility
• The JV partner may have right of first refusal (ROFR)
• Valuation is based on your pro-rata share of facility EBITDA
• Existing management agreements may transfer or need renegotiation

100% Physician-Owned ASC

Less common but increasingly valuable to buyers who want full control:

• Buyers pay premium for no JV partner complications
• Full facility EBITDA is attributable to the sale
• More flexibility in deal structure and post-sale governance
• May require selling physicians to retain minority stake post-close

Who's Buying ASCs in 2026

The ASC buyer landscape is concentrated among a few major players:

National ASC Platforms (Dominant Buyers)

These PE-backed consolidators are the most active acquirers:

• USPI (United Surgical Partners): Tenet-owned, 400+ facilities, aggressive acquirer
• SCA Health: UnitedHealth/Optum-backed, 300+ facilities
• AmSurg/Envision: Major national presence, strong physician relationships
• Specialty Networks: AMSURG spine, orthopedic-focused platforms

Health Systems

Regional and national health systems acquire ASCs to:

• Capture outpatient volume migrating from hospitals
• Lock in physician referral streams
• Participate in high-margin outpatient surgery economics
• Block competitors from entering their market

Private Equity (Direct)

Some PE firms build new platforms or make minority investments alongside existing owners. Typically requires physician commitment to ongoing involvement.

Key Value Drivers for ASCs

Buyers evaluate ASCs differently than practices. Focus on these factors:

Case Volume and Revenue per Case

More cases at higher reimbursement = higher value. Track and optimize:

• Total cases per OR per day
• Revenue per case by specialty
• Case growth trends (quarterly and annually)
• Capacity utilization (are your ORs full?)

Payer Contract Strength

Your fee schedules directly impact EBITDA and valuation:

• Commercial rates vs. Medicare benchmarks
• Out-of-network capabilities and history
• Contract terms and renewal timelines
• Payer mix (commercial vs. government)

Physician Engagement

Buyers want to know physicians will keep bringing cases:

• Physician ownership structure and retention expectations
• Non-compete agreements and exclusivity
• Historical case volume by physician
• Age and retirement timeline of key physicians

Facility and Equipment

• OR count and accreditation status
• Equipment age and capital needs
• Lease terms and renewal options
• Expansion potential (additional ORs, procedure rooms)

The ASC Sale Process

ASC transactions are more complex than practice sales:

Total timeline: 9-15 months from start to close. ASC transactions take longer than practice sales due to regulatory complexity and multi-party negotiations.

Common ASC Valuation Mistakes

1. Ignoring JV partner dynamics: Your partner's ROFR can derail a process. Engage them early.
2. Overstating add-backs: ASC buyers are sophisticated. Aggressive adjustments get discounted.
3. Underestimating physician coordination: If key physicians aren't committed to staying, value drops.
4. Neglecting payer contract timing: Contracts expiring during due diligence create uncertainty.
5. Forgetting about working capital: ASCs have significant AR and inventory. Plan for it.

Next Steps

Ready to explore your ASC options?

• Request Your Confidential ASC Estimate
• Learn About the ASC Sale Process
• Understand PE Buyer Dynamics
• Compare to Practice Valuation Methods